![Barry L. Karger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barry L. Karger
Fondatore presso BioAnalytix, Inc.
Posizioni attive di Barry L. Karger
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioAnalytix, Inc.
![]() BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Fondatore | 01/01/2012 | - |
Corporate Officer/Principal | 01/01/2012 | - |
Storia della carriera di Barry L. Karger
Precedenti posizioni note di Barry L. Karger
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioSystems International SAS
![]() BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Fondatore | 02/12/2009 | 06/03/2014 |
Cetek Corp.
![]() Cetek Corp. Pharmaceuticals: MajorHealth Technology Cetek Corp. discovers and develops pharmaceuticals & drugs. It offers contract drug discovery and collaboration services. The company discovers novel therapeutics by using chemistry, biology, and engineering. Cetek was founded by Dallas E. Hughes in 1996 and is headquartered in Marlborough, MA. | Fondatore | - | - |
Northeastern University
![]() Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | Corporate Officer/Principal | 01/01/1963 | 01/01/1963 |
Formazione di Barry L. Karger
Massachusetts Institute of Technology | Undergraduate Degree |
Cornell University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Francia | 2 |
Posizioni
Founder | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Cetek Corp.
![]() Cetek Corp. Pharmaceuticals: MajorHealth Technology Cetek Corp. discovers and develops pharmaceuticals & drugs. It offers contract drug discovery and collaboration services. The company discovers novel therapeutics by using chemistry, biology, and engineering. Cetek was founded by Dallas E. Hughes in 1996 and is headquartered in Marlborough, MA. | Health Technology |
BioAnalytix, Inc.
![]() BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Technology Services |
BioSystems International SAS
![]() BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Health Technology |
- Borsa valori
- Insiders
- Barry L. Karger
- Esperienza